Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 296
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Pre-Operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
18 and over
Other
02-0484-C
NCT00160875
2.
Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
20 to 75
Pharmaceutical / Industry
01023010 / TOP-003
NCT00284258
Last Modified:
12/1/1998
3.
Phase III Randomized Study of Irinotecan vs Irinotecan/Fluorouracil/Leucovorin vs Fluorouracil/Leucovorin for Untreated Metastatic Colorectal Cancer (Summary Last Modified 12/98)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
Pharmaceutical / Industry
MSKCC-95051
P-UPJOHN-MSKCC-95051, NCI-V96-0913
Last Modified:
5/17/2007
 
First Published:
5/1/1998
4.
Phase III Randomized Study of Leucovorin Calcium Plus Fluorouracil With Either Irinotecan or Oxaliplatin in Patients With Recurrent Metastatic Colorectal Cancer (Summary Last Modified 05/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 to 75
Pharmaceutical / Industry
FRE-GERCOR-C97-3/CPTF308
FRE-C97-3/CPTF301, FRE-C97-3/CPTF308, RP-FRE-C97-3/CPTF308, EU-97044, NCT00003260
Last Modified:
9/10/2008
 
First Published:
5/1/1999
5.
Phase III Randomized Study of Fluorouracil and Leucovorin Calcium With or Without Irinotecan Following Curative Resection in Patients With Stage III Colon Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
18 and over
NCI
CLB-89803
CAN-NCIC-CO15, E-89803, NCCTG-C89803, SWOG-C89803, NCT00003835, C89803, CO15
Last Modified:
6/1/2007
 
First Published:
3/1/2000
6.
Phase III Randomized Study of High-Dose Fluorouracil and Leucovorin Calcium With or Without Irinotecan in Patients With Metastatic Adenocarcinoma of the Colon or Rectum (Summary Last Modified 02/2002)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
EORTC-40986
NCT00004885
Last Modified:
6/18/2008
 
First Published:
4/1/2000
7.
Phase III Randomized Study of Irinotecan Versus Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Patients With Advanced Colorectal Cancer Previously Treated With Fluorouracil
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
NCI
NCCTG-N9841
ECOG-N9841, SWOG-N9841, NCT00005036, N9841
Last Modified:
6/12/2007
 
First Published:
7/1/2000
8.
Phase III Randomized Study of Adjuvant Leucovorin Calcium and Fluorouracil With or Without Irinotecan in Patients With Resected Stage III Colon Cancer at High Risk of Recurrence
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 to 75
Other
FRE-FNCLCC-ACCORD-2
FFCD-9802, EU-20014, NCT00005979
Last Modified:
2/8/2007
 
First Published:
8/1/2000
9.
Phase III Study of Fluorouracil, Leucovorin Calcium, and Irinotecan in Patients With Metastatic, Locally Advanced, or Recurrent Colorectal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
Not specified
NCI
CLB-9864
E-C9864, NCT00006103, C9864
Last Modified:
3/1/2001
 
First Published:
9/1/2000
10.
Phase III Randomized Study of Octreotide in the Prevention of Diarrhea Induced By Irinotecan in Patients With Metastatic Colorectal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care, Treatment
Closed
18 and over
Pharmaceutical / Industry
NOVARTIS-CSMS995US05
NCT00006269
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute